# Title

 Food and Drugs. PART 720â€”VOLUNTARY FILING OF COSMETIC PRODUCT INGREDIENT COMPOSITION STATEMENTS


# ID

 CFR-2018-title21-vol7.Pt. 720


# Structured Analysis Summary

| Type        | Values                                                                  |
|:------------|:------------------------------------------------------------------------|
| Constraints | ['within', 'before', 'after']                                           |
| Duration    | ['30.0 day', '60.0 day', '180.0 day']                                   |
| Condition   | ['until', 'unless', 'where', 'subject to', 'when', 'if']                |
| Entities    | ['Dentifrices', 'Suntan', 'Receipt', 'Food', 'Information', 'Shampoos'] |
| Date        | ['2512-05-01']                                                          |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                  |
|:--------------|:-------------------------------------------------------------------------------------------------------------------------|
| after         | Within 180 days  after forms are made available to the industry, Form                                                    |
| within        | Form FDA 2512 should be filed  within 60 days after the beginning of commercial distribution                             |
| after         | FDA 2512 should be filed within 60 days after the beginning of commercial distribution of any product                    |
| within        | Form FDA 2512 should be filed  within 60 days after the beginning of commercial distribution                             |
| within        | submitted by filing an amended Form FDA 2512 within 60 days after the product is entered into                            |
| after         | an amended Form FDA 2512 within 60 days after  the product is entered into commercial distribution.                      |
| within        | shown by filing an amended Form FDA 2512 within  a year after such changes.                                              |
| after         | an amended Form FDA 2512 within a year after  such changes.                                                              |
| within        | formulation should be submitted by Form FDA 2514 within 180 days after discontinuance of commercial distribution becomes |
| after         | submitted by Form FDA 2514 within 180 days after discontinuance of commercial distribution becomes known to the          |
| after         | (e) If,  after receiving all of the data that are necessary                                                              |
| within        | denied a request for confidentiality or may submit, within 60 days from the date of receipt of                           |
| before        | together with the information that was submitted initially before  making its final determination.                       |
| within        | that an ingredient is not a trade secret within the meaning of &#167;&#8201;20.61 of this chapter constitutes            |
| within        | If suit is brought  within 30 calendar days after such a determination, FDA                                              |
| after         | If suit is brought within 30 calendar days  after such a determination, FDA will not disclose the                        |
| within        | If suit is not brought  within 30 calendar days after a final determination that                                         |
| after         | suit is not brought within 30 calendar days after a final determination that an ingredient is not                        |
| within        | If suit is not brought  within 30 calendar days after a final determination that                                         |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 180.0 day  | Within 180 days after forms are made available to the industry, Form FDA 2512 should be filed for each cosmetic product being commercially distributed as of the effective date of this part.                                                                                                                                                                                                                 |
| 60.0 day   | Form FDA 2512 should be filed within 60 days after the beginning of commercial distribution of any product not covered within the 180-day period.                                                                                                                                                                                                                                                             |
| 180.0 day  | Form FDA 2512 should be filed within 60 days after the beginning of commercial distribution of any product not covered within the 180-day period.                                                                                                                                                                                                                                                             |
| 60.0 day   | Changes in the information requested under &#167;&#167;&#8201;720.4 (a)(3) and (a)(5) on the ingredients or brand name of a cosmetic product should be submitted by filing an amended Form FDA 2512 within 60 days after the product is entered into commercial distribution.                                                                                                                                 |
| 180.0 day  | Notice of discontinuance of commercial distribution of a cosmetic product formulation should be submitted by Form FDA 2514 within 180 days after discontinuance of commercial distribution becomes known to the person filing.                                                                                                                                                                                |
| 60.0 day   | The petitioner may withdraw the records for which FDA has tentatively denied a request for confidentiality or may submit, within 60 days from the date of receipt of the written notice of the tentative denial, additional relevant information and arguments and request that the agency reconsider its decision in light of both the additional material and the information that it originally submitted. |
| 30.0 day   | If suit is brought within 30 calendar days after such a determination, FDA will not disclose the records involved or require that the disputed ingredient or ingredients be disclosed in labeling until the matter is finally determined in the courts.                                                                                                                                                       |
| 30.0 day   | If suit is not brought within 30 calendar days after a final determination that an ingredient is not a trade secret within the meaning of 21 CFR 20.61, and the petitioner does not withdraw the records for which a request for confidentiality has been denied, the records involved will be made a part of FDA files and will be available for public disclosure upon request.                             |


## Condition

| Condition   | Context                                                                                                                                   |
|:------------|:------------------------------------------------------------------------------------------------------------------------------------------|
| where       | How and  where  to file.                                                                                                                  |
| if          | of the manufacturer or packer of the product if  d                                                                                        |
| when        | person designated on the label of the product, when the manufacturer or packer submits the information requested                          |
| when        | (4) Provide ingredient information (and,  when requested, ingredient samples) to a licensed physician who,                                |
| when        | designated as such without naming each individual ingredient when the manufacturer or supplier of the fragrance and/or                    |
| if          | of this chapter, its common or usual name, if it has one, or its chemical or technical                                                    |
| if          | in which case such mixture should be ident if ied as &#8220;fragrance,&#8221; &#8220;flavor,&#8221; &#8220;fragrance and flavor&#8221; or |
| unless      | with paragraphs (d)(2) and (d)(3) of this section, unless such mixture is a formulation voluntarily registered on                         |
| when        | fragrance and/or flavor should be listed as such. when                                                                                    |
| where       | two or more shades of a cosmetic product where only the amounts of the color additive ingredient                                          |
| where       | two or more shades of a cosmetic product where only the amounts of the color additive ingredient                                          |
| where       | Drug Administration (FDA) reference number in those cases where  a permanent number cannot be assigned.                                   |
| subject to  | The request for confidentiality will also be  subject to the provisions of &#167;&#8201;20.111 of this chapter, as                        |
| if          | trade secrecy of its tentative determination in writing. if                                                                               |
| if          | was submitted initially before making its final determination. if                                                                         |
| subject to  | this chapter constitutes final agency action that is subject to  judicial review under 5 U.S.C. Chapter 7.                                |
| until       | disputed ingredient or ingredients be disclosed in labeling until  the matter is finally determined in the courts.                        |


## Entities

| Entities    | Context                                                   |
|:------------|:----------------------------------------------------------|
| Food        | Food  and Drugs.                                          |
| Information | Information  requested about cosmetic products.           |
| Shampoos    | (vi)  Shampoos  (noncoloring).                            |
| Dentifrices | (i)  Dentifrices  (aerosol, liquid, pastes, and powders). |
| Suntan      | (13)  Suntan  preparations.                               |
| Suntan      | (i)  Suntan  gels, creams, and liquids.                   |
| Receipt     | Receipt of the form will be acknowledged by sending       |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2512-05-01 | However, except for the hair coloring preparations listed in paragraph (c)(6) of this section for which a statement for each shade of such product is required, a single Form FDA-2512 may be filed for two or more shades of a cosmetic product where only the amounts of the color additive ingredient used are varied or in the case of flavors and fragrances where only the amounts of the flavors and fragrances used are varied. |


